SCHEMBL294067

SCHEMBL294067

CCC(C)N(C)CC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAOB P27338 13/20 0.41
MAOA P21397 1/20 0.36
FFAR3 O14843 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17935549 1.00 MAOB (0.41) MAOBMAOAFFAR3
SCHEMBL13464159 0.81 ALDH1A1 (0.35)
SCHEMBL13591210 0.80 FFAR3 (0.38) MAOBFFAR3
SCHEMBL25733538 0.79 CHRNB2 (0.41) MAOB
SCHEMBL15284072 0.78 FFAR3 (0.36) FFAR3
SCHEMBL21513093 0.77 ACE (0.36) MAOBFFAR3
SCHEMBL20254227 0.77 ALDH1A1 (0.41) FFAR3
SCHEMBL893034 0.77
SCHEMBL867753 0.77
SCHEMBL5983944 0.77 GPR84 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746997-A1 A PROCESS FOR THE ENZYMATIC CO2 CAPTURE USING A STABILIZED CARBONIC ANHYDRASE Saipem S.p.A. (IT) 2026-05-27 EP claimed
WO-2025017532-A1 A PROCESS FOR THE ENZYMATIC CO2 CAPTURE USING A STABILIZED CARBONIC ANHYDRASE SAIPEM S.P.A. (IT) 2025-01-23 WO claimed
EP-3185992-B1 CO2 CAPTURE METHOD AND SYSTEM USING THERMOVIBRIO AMMONIFICANS CARBONIC ANHYDRASE SAIPEM SPA (IT) 2023-03-08 EP claimed
US-20220186202-A1 CARBONIC ANHYDRASE VARIANTS FOR IMPROVED CO2 CAPTURE SAIPEM S.P.A. (IT) 2022-06-16 US claimed
EP-3947669-A1 CARBONIC ANHYDRASE VARIANTS FOR IMPROVED CO2 CAPTURE Saipem S.p.A. (IT) 2022-02-09 EP claimed
CN-112533688-A Post combustion CO via heat recovery and integration2Capture 塞彭公司 2021-03-19 CN claimed
EP-2490791-B1 PROCESS FOR CO2 CAPTURE USING CARBONATES AND BIOCATALYSTS CO2 SOLUTION INC (CA) 2017-07-05 EP claimed
EP-2461894-B1 PROCESS FOR CO2 CAPTURE USING MICRO-PARTICLES COMPRISING BIOCATALYSTS CO2 SOLUTIONS INC (CA) 2017-06-14 EP claimed
CN-102548643-B CO capture using microparticles comprising biocatalysts2Method (2) CO2 SOLUTIONS INC. (CA) 2014-10-22 CN claimed
CN-103429318-A C02 treatments using enzymatic particles sized according to reactive liquid film thickness for enhanced catalysis CO2 SOLUTION INC 2013-12-04 CN claimed
CN-102574053-A Formulation and process for co2 capture using carbonates and biocatalysts CO2 SOLUTION INC 2012-07-11 CN claimed
CN-102548643-A CO capture using microparticles comprising biocatalysts2Method (2) CO2 SOLUTION INC 2012-07-04 CN claimed
CN-102548644-A Formulation and process for CO2 capture using amino acids and biocatalysts CO2 SOLUTION INC 2012-07-04 CN claimed
EP-0081301-B1 A STERICALLY HINDERED AMINO ACID PROMOTED ACID GAS SCRUBBING PROCESS EXXON RESEARCH AND ENGINEERING COMPANY (US) 1985-08-28 EP claimed
EP-4746997-A1 A PROCESS FOR THE ENZYMATIC CO2 CAPTURE USING A STABILIZED CARBONIC ANHYDRASE Saipem S.p.A. (IT) 2026-05-27 EP disclosed
US-20260078363-A1 RECOMBINANT CARBONIC ANHYDRASE POLYPEPTIDES AND METHODS OF USE THEREOF KALYAANAMOORTHY SUBHA (CA) 2026-03-19 US disclosed
US-12440799-B2 Post-combustion CO2 capture with heat recovery and integration SAIPEM S.P.A. (IT) 2025-10-14 US disclosed
EP-1633384-A2 STABLE ANALOGS OF PEPTIDE AND POLYPEPTIDE THERAPEUTICS Trustees of Tufts College (US) 2006-03-15 EP disclosed
US-20050049177-A1 Stable analogs of peptide and polypeptide therapeutics TRUSTEES OF TUFTS COLLEGE (US) 2005-03-03 US disclosed
WO-2004103390-A2 STABLE ANALOGS OF PEPTIDE AND POLYPEPTIDE THERAPEUTICS TRUSTEES OF TUFTS COLLEGE (US) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050049177-A1 Stable analogs of peptide and polypeptide therapeutics IAPP, VIP, PREP MAOB 4438/4885MAOA 4500/4885FFAR3 2027/4885
US-20260078363-A1 RECOMBINANT CARBONIC ANHYDRASE POLYPEPTIDES AND METHODS OF USE THEREOF CA13, CA9, CA12 MAOB 4096/4885MAOA 4504/4885FFAR3 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.